PT Kedoya Adyaraya Tbk

rsgk

Overview

RSGK Overview

PT Kedoya Adyaraya Tbk is an Indonesia-based company, which is engaged in providing healthcare services. The Company provides a range of services, such as advanced medical rehabilitation, cardiovascular center, stroke center, and trauma center. The Company has introduced robotic assisted rehabilitation therapy tools called LEXO and DIEGO. Robotic Rehabilitation is be used for the recovery process in patients with the following medical indications, such as stroke, brain injury, spinal cord injury, multiple sclerosis, Parkinson's disease, and post cruciate ligament reconstruction. Its cardiovascular center provides integrated services ranging from screening, diagnostics, therapy, and rehabilitation. Its stroke center provides integrated and comprehensive services for handling all problems that arise in connection with stroke. Its trauma center provides various services, such as Emergency services, head trauma, face and dental trauma, and limb trauma.

246ValueCompetitiveFutureFinancialsDividend
Exchange
Indonesia Stock Exchange

Symbol: RSGK

Main
Market Cap.
IDR 1.04Trillion

~$65.07M USD

Industry
Healthcare Providers
Sub-Industry
Healthcare Providers
Sector
Healthcare

Valuation

RSGK Valuation Metrics

1,120

IDR
0.0%

Closing Price on 2024-04-17

Price to Equity

41.34

P/E

At 41.34x P/E TTM, RSGK.JK is trading at a premium to its peers in the Healthcare Equipment & Providers sector (avg 16.9x).

Price to Book

1.39

P/B

At 1.39x P/B TTM, RSGK.JK is trading at a discount to its peers in the Healthcare Equipment & Providers sector.

Price to Sales

2.79

P/S

At 2.79x P/S TTM, RSGK.JK is trading in line with its peers in the Healthcare Equipment & Providers sector.

Valuing PT Kedoya Adyaraya Tbk based on its trailing twelve months (TTM) valuation metrics against its peers in the Healthcare Equipment & Providers sector

Historical Price to Earnings

Other Valuation Metrics

Valuing PT Kedoya Adyaraya Tbk relative to other stocks in the Healthcare Equipment & Providers sector

Price/Cash Flow
36.95x
Price/Forward Earnings
-
Enterprise Value/Revenue
2.58x
Enterprise Value/EBITDA
21.77x
PEG Ratio
-0.64x

Analyst Ratings

No analyst ratings available yet.

Last closing: IDR1,1202024-04-17
IDR 353.59

Considerably Lower Intrinsic Value: Analyst's intrinsic value is of RSGK is IDR354, which is 67% lower than RSGK's last closing price of IDR1,120 (as of 2024-04-17).

Valuation Recap of RSGK stock
WeightNotesScore
High
The P/E ratio is calculated by dividing the market price of a company's stock by its earnings per share (EPS). It is a key tool for investors and analysts to assess whether a stock is overvalued, undervalued, or fairly valued. A P/E ratio of 41.34x is above the ID market average of 8.46x and is trading at a premium to peers in the Healthcare Equipment & Providers sector (16.91x). In fact, less than 25% of its peers trade at a higher P/E ratio than RSGK.

High
The P/B ratio is calculated by dividing the market price of a company's stock by its book value per share (BVPS). It measures the company's stock value relative to its assets minus liabilities. A P/B ratio of 1.39x is similar to the peers average of 1.69x in the Healthcare Equipment & Providers sector. In fact, less than 25% of its peers trade at a lower P/B ratio than RSGK.

Medium
The P/S ratio is calculated by dividing the market price of a company's stock by its sales per share. It measures the company's stock value relative to its sales. A P/S ratio of 2.79x is similar to the peers average of 2.87x in the Healthcare Equipment & Providers sector. When considered alongside the Forward Price/Earnings ratio, they serve to illustrate investors' expectations of RSGK's valuation relative to its current sales and future earnings growth.

Low
The Price/Cash Flow ratio (P/CF) is calculated by dividing the market price of a company's stock by its cash flow per share. It measures the company's stock value relative to its cash flow, and is sometimes said to be a more objective measure of a company's value because cash flows cannot be manipulated as easily as earnings, which considers non-cash items such as depreciation and amortization. RSGK's P/CF ratio of 36.95x is considered a relatively high ratio by analysts.

Low
The Enterprise Value/Revenue ratio (EV/R) is calculated by dividing the enterprise value of a company by its revenue. It measures the company's enterprise value relative to its revenue. It is an indicator of how much it costs to buy the company's revenue; the lower the ratio, the cheaper the company's revenue. RSGK's EV/R ratio of 2.58x is considered fairly underpriced by the market The average EV/R ratio for the Healthcare Equipment & Providers sector is 2.95x.

Medium
Considerably Lower Intrinsic Value: Analyst's intrinsic value is of RSGK is IDR 353.59, which is 67% lower than RSGK's last closing price of IDR 1,120.00.

Peers

RSGK Peers and Comparison

Peer Companies

Supertype Fuzzy Search
SymbolCompany Name
Market Cap
(in Trillion IDR)
Total Assets
(in Trillion IDR)
Total Revenue
(in Trillion IDR)
Profit and Loss
(in Trillion IDR)
P/E
P/B
KLBFKalbe Farma Tbk65.45T27.06T 30.45T 2.77T 23.663.06
MIKAPT Mitra Keluarga Karyasehat Tbk.36.85T7.34T 4.26T 0.92T 40.236.33
SILOPT Siloam International Hospitals Tbk.31.10T10.98T 11.19T 1.21T 25.683.93
SRAJSejahteraraya Anugrahjaya Tbk20.58T5.61T 2.50T -0.04T -534.7211.09
SIDOPT Industri Jamu Dan Farmasi Sido Muncul Tbk19.95T3.89T 3.57T 0.95T 20.995.89
HEALPT Medikaloka Hermina Tbk.16.86T8.80T 5.78T 0.44T 38.544.36
PRAYPT Famon Awal Bros Sedaya Tbk9.56T4.70T 1.84T 0.22T 44.073.42
TSPCTempo Scan Pacific Tbk8.66T11.32T 13.12T 1.18T 7.351.12
SOHOPT Soho Global Health Tbk6.24T4.75T 8.20T 0.37T 16.822.60
OMEDPT Jayamas Medica Industri Tbk5.33T2.58T 1.74T 0.26T 20.552.40
Competitiveness Recap of RSGK stock
WeightNotesScore
High
At a market cap of IDR 1,041.24 billion, RSGK.JK ranks 10 in Market Cap out of 10 companies in the Healthcare sector.

High
At a PE of 41.34, RSGK.JK ranks 2 out of 10 companies in the Healthcare sector for P/E value. The average PE is -27.60 (unadjusted). A high P/E ratio often indicates higher growth expectation, or other qualitative factors that led investors to believe that the company has a defensible competitive advantage compared to its peers in Healthcare. In this regard, it trails behind sector leaders such as PT Famon Awal Bros Sedaya Tbk (44.07) in the Healthcare sector.

Medium
At a PE of 41.34, RSGK.JK is trading at a higher PE than that of its subsector peers in Healthcare Equipment & Providers (median of 16.91). false

Medium
At a revenue of IDR 0.37 trillion, RSGK.JK ranks 10 in Revenue out of 10 companies in the Healthcare sector.

Medium
At a profit of IDR 0.03 trillion, RSGK.JK ranks 9 in Profit out of 10 companies in the Healthcare sector.

Future

Future Growth of RSGK

Growth Forecasts

No data available

Sector Benchmark

Healthcare Equipment & Providers companies in Indonesia are growing at a projected rate of 9.82% against the IDX average of +7.6%.

Healthcare Equipment & Providers sector overview
No data is available for RSGK at the moment.
Future growth prospect of RSGK
WeightNotesScore
High
RSGK's projected growth rate of 9.82% is above the ID market average of 7.62%.

Medium
RSGK and its peers in the Healthcare Equipment & Providers sub-sector belongs to the Healthcare sector. Companies in the Healthcare sector are projected to have a challenging year heading into 2024. Specifically, earnings are projected to decrease by 0.00% in 2024 while revenue growth is projected to decrease by -5.79%. These macroeconomic trends will likely be a headwind for RSGK's earnings growth prospects in the next 2 years.

Loading...
Loading...

Management

Executive Management

President Director

Dr. Liem Kian Hong15.2 years
Hendra Munanto
Director
Dr. Juniwati Gunawan
Director
Armen Antonius Djan
Director
NamePositionShares%
Hungkang SutedjaCommissioner3,300,0000.35
Expressed in millions IDR, unless otherwise stated

Ownership

RSGK Ownership

Others
7.03%
Insiders
92.97%
Institutions
0%
NameNumber of SharesOwnership (%)Value
Pt Sarana Meditama Metropolitan Tbk742,242,20079.84831.31B
Pt Bestama Medikacenter Investama122,055,54013.13136.70B
Public (Scripless)62,077,2606.6869.53B
Hungkang Sutedja3,300,0000.353.70B
No data is available for RSGK at the moment.